the Soy Story
HOME MEDIA RELEASES WHAT'S NEW IN RESEARCH? INTERVIEW CONTACTS GLOSSARY
Search
What is Soy?
Soy Foods for Health
Soy and Heart Disease
Soy and Cancer
Soy and Osteoporosis
Soy and Women's Health
Soy Foods for diabetes
Soy and Infant Formula
Soy and Sports Nutrition
Commonly Asked Questions
Bibliography/Reference
Soy & Heart Disease

References for Soy & Heart Disease:

  1. World Health Organisation (WHO), Cardiovascular Diseases, Statistics. http://www.who.int/topics/cardiovascular_diseases/en/
  2. Meeker DR & Kesten HD (1940) Experimental atherosclerosis and high protein diets. Proceedings of the Society for Experimental Biology and Medicine 45, 543-545.
  3. Meeker DR & Kesten HD (1941) Effect of high protein diets on experimental atherosclerosis of rabbits. Archives of Pathology 31, 147-162.
  4. Anderson JW, Johnstone BM, Cook-Newell ME, Meta-Analysis of the effects of soy protein intake on serum lipids, N Eng J Med 1995;333:276-282.
  5. Weggemans RM and Trautwein EA. Relation between soy-associated isoflavones and LDL and HDL cholesterol concentrations in humans: a meta-analysis. European Journal of Clinical Nutrition, 2003. 57:940-946.
  6. Zhan S, Ho SC. Meta-analysis of the effects of soy protein containing isoflavones on the lipid profile. American Journal of Clinical Nutrition. 2005 Feb; 81(2):397-408.
  7. Taku K, Umegaki K et al. Soy isoflavones lower serum total and LDL cholesterol in humans: a meta-analysis of 11 randomized controlled trials. American Journal of Clinical Nutrition, 2007;85:1148-56.
  8. Sirtori C.R., Eberini I and Arnoldi A. Hypocholesterolaemic effects of soya proteins: results of recent studies are predictable from the Anderson meta-analysis data. British Journal of Nutrition, 2007;00, 1-8.
  9. Cassidy A and Hooper L. Phytoestrogens and cardiovascular disease. J Brit Menopause Society, 2006; 12(2): 49-56.
  10. Kokubo Y, Iso H, Ishihara J et al. Association of dietary intake of soy, beans and isoflavones with risk of cerebral and myocardial infarctions in Japanese Populations - The Japan Public Health Centre-based (JPHC) Study Cohort I. Circulation. 2007 Nov; 116: 2553-2562.
  11. Anderson JW. Soy food effects on serum lipoprotein in humans: updated meta-analysis (abstract). Sixth International Symposium on the Role of Soy in Preventing and Treating Chronic Disease (November; Chicago, IL) 2005.
  12. Crouse JR III, Morgan T, Terry JG, et al., A randomized trial comparing the effect of casein with that of soy protein containing varying amounts of isoflavones on plasma concentrations of lipids and lipoproteins, Arch Intern Med 1999;159:2070-2076.
  13. Clerici C, Setchell K, et al. Pasta naturally enriched with isoflavone aglycons from soy germ reduces serum lipids and improves markers of cardiovascular risk. Journal of Nutrition. 2007.
  14. Simons LA, von Konigsmark M, Simons J, et al., Phytoestrogens do not influence lipoprotein levels or endothelial function in healthy, postmenopausal women, Am J Cardiol 2000;85:1297-301.
  15. Setchell KDR, Brown NM. et al. The clinical importance of the metabolite equol - A clue to the effectiveness of soy and its isoflavones, Critical Review. J Nutr, 2002; 132:3577-3584.
  16. Azadbakht L, Kimiagar M et al. Soy inclusion in the diet improves features of the metabolic syndrome: a randomised crossover study in postmenopausal women. Am J Clin Nutr 2007; 85:735-41.
  17. Gardner CD, Messina M et al. Effect of two types of soymilk and dairy milk on plasma lipids in hypercholesterolemic adults: a randomised trial. J Am Col Nutr. 2007; 26(6): 669-677.
  18. Matthan NR, Jalbert Sm et al. Effect of soy protein from different processed products on cardiovascular disease risk factors and vascular endothelial function in hypercholesterolemic subjects. Am J Clin Nutr 2007; 85:960-6.
  19. Liang Y.L., Teede H. Et al. The effects of phytoestrogen on blood pressure and lipids in healthy volunteers. Zhonghua Xin Xue Guan Bing Za Zhi 2006. 34(8):726-9.
  20. Sagara M, Kanda T et al. Effects of dietary intake of soy protein and isoflavones on cardiovascular disease risk factors in high risk, middle-aged men in Scotland. J Am coll Nutr. 2004, 23(1):85-31.
  21. Yang G., Shu X.O., et al. Longitudinal study of soy food intake and blood pressure among middle-aged and elderly Chinese women. Am J Cinl Nutr 2005;81(5):1012-7.
  22. Hodgson JM, Croft KD, Puddey IB, et al., Soybean isoflavonoids and their metabolic products inhibit in vitro lipoprotein oxidation in serum, J Nutr Biochem 1996;7:664-669.
  23. Jenkins DJ, Kendall CW, et al. Effects of high- and low-isoflavone soyfoods on blood lipids, oxidized LDL, homocysteine, and blood pressure in hyperlipidemic men and women. Am. J. Clinical Nutrition, Aug 2002; 76: 365 - 372.
  24. Jenkins DJ, Kendall CW, et al, Effect of soy-based breakfast cereal on blood lipids and oxidized low-density lipoprotein. Metabolism. 2000 Nov;49(11):1496-500.
  25. Jenkins DJ, Kendall CW, et al, The effect on serum lipids and oxidized low-density lipoprotein of supplementing self-selected low-fat diets with soluble-fiber, soy, and vegetable protein foods. Metabolism. 2000 Jan;49(1):67-72.
  26. Azadbakht L, Kimiagar M. Dietary soya intake alters plasma antioxidant status and lipid peroxidation in postmenopausal women with the metabolic syndrome. British Journal of Nutrition, 2007 May 17; 1-7 (Epub ahead of print).
  27. Colacurci N., Chiantera A. Et al. Effects of soy isoflavones on endothelial function in healthy post-menopasual women. Menopasue 2005; 12(3):299-307.
  28. Azadbakht L, Kimiagar M. Soy consumption, markers of inflammation, and endothelial function: a cross-over study in postmenopausal women with the metabolic syndrome. Diabetes Care, 2007 Apr; 30(4):967-73.
  29. Chan YP., Lau KK. Et al. Isoflavone intake in persons at high risk of cardiovascular events: implications for vascular endothelial function and the carotid atherosclerotic burden. Am J Clin Nutr 2007;86:938-45.
  30. Food Labelling: health claims: soy protein and coronary heart disease. Food and Drug Administration, HHS: final rule: soy protein and coronary heart disease. Fed Reg. 1999;64:57700-57733.
  31. American Heart Association, Soy Protein, isoflavones and cardiovascular health, an American Heart Association Science Advisory for Professionals from the Nutrition Committee. Circulation 2006; 113:000-000.
  32. Australian Bureau of Statistics (ABS). Cardiovascular disease in Australia: A snapshot, 2004-05. http://www.abs.gov.au/ausstats/abs@.nsf/mf/4821.0.55.001#
  33. Australian Institute of Health and Welfare and the National Heart Foundation. Heart, stroke and vascular diseases - Australian facts 2004. http://www.heartfoundation.org.au/document/NHF/Stats_aihw_hsvd_04_final.pdf
  34. Australian Institute of Health and Welfare 2005a, Health system expenditure on disease and injury in Australia, 2000-01. 2nd edition, AIHW Cat. No. HWE 26, AIHW, Canberra.
  35. The National Heart Foundation of New Zealand, David R. Hay. Cardiovascular disease in New Zealand, 2004. A summary of recent statistical information. http://www.nhf.org.nz/files/NHF6949%20TechReport82.pdf